Align Technology, Inc.

ALGN Healthcare Medical Instruments & Supplies

Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024.

Revenue
+1.92%
EPS
+143.9%
Free cash flow
+8.26%

Quarter to September 2026, against a year earlier

160.79 1.42 +0.89%
Market cap
$11.3B
P/E
23.1×
Fwd P/E
20.4×
Dividend yield
—
F-score
6/9
Altman Z
4.73
Beneish M
−2.52
Dividend safety
n/a
Older periods Dec '25 Mar '26 Jun '26 Sep '26
ROE

+8 more TTM periods

10.39% 10.82% 10.16% 0.00%
Piotroski F-Score
6 8 7 9
ROA
6.59% 6.92% 6.55% 7.71%
ROIC
11.55% 11.26% 10.93% 12.27%
Return on Tangible Assets
22.45% 23.14% 22.13% 25.26%
Average Days of Receivables
99.66 100.27 101.26 102.15
Free Cash Flow per Share
6.77 8.17 9.45 10.56
Free Cash Flow
490.78 583.65 675.57 749.89
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026